Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Centrifuge Operation for Cell Removal – V 2.0

Posted on By


Biosimilars: SOP for Centrifuge Operation for Cell Removal – V 2.0


Standard Operating Procedure for Centrifuge Operation for Cell Removal in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/152/2025
Supersedes SOP/BS/152/2022
Page No. Page 1 of 10
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To provide a detailed procedure for the operation of centrifuges for removing cells and cell debris from harvested biosimilar culture fluid prior to downstream processing under Good Manufacturing Practice (GMP) guidelines.

2. Scope

This SOP is applicable to the use of continuous-flow or batch centrifuges used in biosimilar upstream processing facilities for the separation of biomass post-harvest.

3. Responsibilities

  • Production: Set up, operate, and monitor centrifuge system; document operations and report deviations.
  • Engineering: Perform equipment maintenance and calibration as per schedule.
  • QA: Review logbooks and approve operation before and after use for GMP batches.

4. Accountability

The Upstream Manufacturing Lead is accountable for ensuring compliance with the centrifuge operation procedure during batch harvest in biosimilar production.

5. Procedure

5.1 Pre-Operational Checks

  1. Verify equipment ID, status label, and cleaning status.
  2. Ensure balance of rotor assembly and inspect seals and gaskets.
  3. Check calibration validity of RPM, temperature, and timer controls.
  4. Record pre-checks in Annexure-1: Centrifuge Pre-Use Checklist.

5.2 Loading and Setup

  1. Connect the harvest vessel outlet to the centrifuge inlet line using sterile connectors.
  2. Ensure the clarified supernatant outlet and sludge outlet lines are properly routed to respective collection tanks.
  3. Set desired parameters on the control panel:
    • RPM: 3500–6000 (as per process)
    • Feed flow rate: 1–3 L/min
    • Discharge cycle: As defined in batch record

5.3 Operation

  1. Start the centrifuge and allow it to reach set RPM.
  2. Begin feeding harvest fluid at low flow and gradually increase to setpoint.
  3. Monitor:
    • Motor load
    • Vibration levels
    • Feed tank level
    • Clarified output turbidity (if applicable)
  4. Periodically discharge sludge manually or automatically as per cycle setting.

5.4 Completion and Cleaning

  1. Once feed is complete, run rinse cycle with WFI or designated buffer for 5–10 minutes.
  2. Shut down centrifuge following OEM procedure.
  3. Disassemble rotors and clean surfaces if required as per Annexure-2: Cleaning Log.

5.5 Documentation

  1. Enter operation data including:
    • Start/end time
    • Total volume processed
    • RPM and cycle durations
    • Observations or abnormalities
  2. Attach printouts from control panel (if available) to batch documentation.

5.6 Deviation Management

  1. Report any of the following as deviation:
    • RPM deviation beyond 5%
    • Leakage or foam formation
    • Unexpected shutdown or discharge failure
  2. Record in deviation log and inform QA immediately.

6. Abbreviations

  • RPM: Revolutions Per Minute
  • WFI: Water for Injection
  • OEM: Original Equipment Manufacturer
  • QA: Quality Assurance

7. Documents

  1. Centrifuge Pre-Use Checklist – Annexure-1
  2. Centrifuge Cleaning Log – Annexure-2
  3. Centrifuge Operation Summary – Annexure-3

8. References

  • WHO TRS 999 – GMP for Biotherapeutic Products
  • OEM Equipment Manual – Alfa Laval / GE Centritech
  • EU GMP Annex 1 – Manufacture of Sterile Medicinal Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Centrifuge Pre-Use Checklist

Date Equipment ID Rotor Check Seals Check Status Checked By
04/05/2025 CF-102 OK OK Ready Ajay Verma

Annexure-2: Centrifuge Cleaning Log

Date Equipment ID Cleaning Agent Contact Time Rinsed (Y/N) Cleaned By
04/05/2025 CF-102 NaOH 0.5% 10 min Y Sunita Reddy

Annexure-3: Centrifuge Operation Summary

Batch No. Start Time End Time RPM Volume (L) Operator
BS-DP-081 09:00 10:15 4200 85 Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Included clarification on flow rate and cleaning validation Process standardization
See also  Biosimilars: SOP for Endotoxin Testing in Cell Culture - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Analytical Method Development: SOP for Solution Stability Studies – V 2.0
Next Post: Gel Manufacturing: SOP for Environmental Monitoring During Gel Production – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version